Boston Scientific · Operating Cash Flow (Statement)

Latest reported$4.53Bperiod endingJun 30, 2026

BSX TTM Cash from Operations ($42.50M → $4.53B)

TTM operating cash flow (statement)

High-resolution chart · PNG

BSX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Boston Scientific Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2001	569,000,000
Mar 31, 2001	683,000,000
Dec 31, 2000	739,000,000
Sep 30, 2000	727,000,000
Jun 30, 2000	836,000,000
Mar 31, 2000	785,000,000
Dec 31, 1999	775,000,000
Sep 30, 1999	765,000,000
Jun 30, 1999	531,000,000
Mar 31, 1999	361,000,000
Dec 31, 1998	258,000,000
Sep 30, 1998	118,700,000
Jun 30, 1998	62,600,000
Mar 31, 1998	48,100,000
Dec 31, 1997	80,500,000
Sep 30, 1997	117,200,000
Jun 30, 1997	181,500,000
Mar 31, 1997	170,400,000
Dec 31, 1996	140,300,000
Sep 30, 1996	93,300,000
Jun 30, 1996	12,100,000
Mar 31, 1996	29,900,000
Dec 31, 1995	25,000,000
Sep 30, 1995	38,700,000
Jun 30, 1995	74,700,000
Mar 31, 1995	76,900,000
Dec 31, 1994	67,800,000
Sep 30, 1994	65,700,000
Jun 30, 1994	69,100,000
Mar 31, 1994	70,300,000
Dec 31, 1993	65,800,000
Sep 30, 1993	59,100,000
Jun 30, 1993	55,100,000
Mar 31, 1993	48,900,000
Dec 31, 1992	42,500,000